National Emergency Care Enterprise


Book Description

In 2006, the Institute of Medicine (IOM) released a series of three books on the Future of Emergency Care in the United States Health System. These reports contained recommendations that called on the federal government and private stakeholders to initiate changes aimed at improving the emergency care system. Three years later, in May 2009, the IOM convened a workshop to examine the progress to date in achieving these objectives, and to help assess priorities for future action. The May 2009 workshop, summarized in this volume, brought stakeholders and policy makers together to discuss which among the many challenges facing emergency care are most amenable to coordinated federal action. The workshop sought to foster information exchange among federal officials involved in advancing emergency care and key stakeholder groups from around the country.




National Emergency Care Enterprise


Book Description

In 2006, the Institute of Medicine (IOM) released a series of three books on the Future of Emergency Care in the United States Health System. These reports contained recommendations that called on the federal government and private stakeholders to initiate changes aimed at improving the emergency care system. Three years later, in May 2009, the IOM convened a workshop to examine the progress to date in achieving these objectives, and to help assess priorities for future action. The May 2009 workshop, summarized in this volume, brought stakeholders and policy makers together to discuss which among the many challenges facing emergency care are most amenable to coordinated federal action. The workshop sought to foster information exchange among federal officials involved in advancing emergency care and key stakeholder groups from around the country.




Ensuring an Effective Public Health Emergency Medical Countermeasures Enterprise


Book Description

The U.S. medical countermeasures (MCMs) enterprise is interconnected, complex, and dynamic. It includes public and private entities that develop and manufacture new and existing MCMs, ensure procurement, storage, and distribution of MCMs, and administer, monitor, and evaluate MCMs. The interagency group known as the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) is the nation's sole coordinating body, responsible for ensuring end-to-end MCM preparedness and response. Ensuring an Effective Public Health Emergency Medical Countermeasures Enterprise provides recommendations from an expert committee for a re-envisioned PHEMCE. Four priority areas of improvement emerged from committee deliberations: (1) articulating PHEMCE's mission and role and explicating the principles guiding PHEMCE's operating principles and processes, (2) revising PHEMCE operations and processes, (3) collaborating more effectively with external public and private partners, and (4) navigating legal and policy issues.




Value and Quality Innovations in Acute and Emergency Care


Book Description

This text analyses how acute and emergency care can be more efficient, featuring twenty case studies of successful innovations.










For-Profit Enterprise in Health Care


Book Description

"[This book is] the most authoritative assessment of the advantages and disadvantages of recent trends toward the commercialization of health care," says Robert Pear of The New York Times. This major study by the Institute of Medicine examines virtually all aspects of for-profit health care in the United States, including the quality and availability of health care, the cost of medical care, access to financial capital, implications for education and research, and the fiduciary role of the physician. In addition to the report, the book contains 15 papers by experts in the field of for-profit health care covering a broad range of topicsâ€"from trends in the growth of major investor-owned hospital companies to the ethical issues in for-profit health care. "The report makes a lasting contribution to the health policy literature." â€"Journal of Health Politics, Policy and Law.




Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease


Book Description

Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.